001     154031
005     20240610121112.0
024 7 _ |a 10.1007/s10439-013-0922-3
|2 doi
024 7 _ |a WOS:000331976300011
|2 WOS
037 _ _ |a FZJ-2014-03445
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Fedosov, Dmitry
|0 P:(DE-Juel1)140336
|b 0
245 _ _ |a Computational biorheology of human blood flow in health and disease
260 _ _ |a Dordrecht [u.a.]
|c 2014
|b Springer Science + Business Media B.V
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1402639068_14237
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
520 _ _ |a Hematologic disorders arising from infectious diseases, hereditary factors and environmental influences can lead to, and can be influenced by, significant changes in the shape, mechanical and physical properties of red blood cells (RBCs), and the biorheology of blood flow. Hence, modeling of hematologic disorders should take into account the multiphase nature of blood flow, especially in arterioles and capillaries. We present here an overview of a general computational framework based on dissipative particle dynamics (DPD) which has broad applicability in cell biophysics with implications for diagnostics, therapeutics and drug efficacy assessments for a wide variety of human diseases. This computational approach, validated by independent experimental results, is capable of modeling the biorheology of whole blood and its individual components during blood flow so as to investigate cell mechanistic processes in health and disease. DPD is a Lagrangian method that can be derived from systematic coarse-graining of molecular dynamics but can scale efficiently up to arterioles and can also be used to model RBCs down to the spectrin level. We start from experimental measurements of a single RBC to extract the relevant biophysical parameters, using single-cell measurements involving such methods as optical tweezers, atomic force microscopy and micropipette aspiration, and cell-population experiments involving microfluidic devices. We then use these validated RBC models to predict the biorheological behavior of whole blood in healthy or pathological states, and compare the simulations with experimental results involving apparent viscosity and other relevant parameters. While the approach discussed here is sufficiently general to address a broad spectrum of hematologic disorders including certain types of cancer, this paper specifically deals with results obtained using this computational framework for blood flow in malaria and sickle cell anemia.
536 _ _ |a 451 - Soft Matter Composites (POF2-451)
|0 G:(DE-HGF)POF2-451
|c POF2-451
|f POF II
|x 0
700 1 _ |a Dao, M.
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Karniadakis, G. E.
|0 P:(DE-HGF)0
|b 2
|e Corresponding Author
700 1 _ |a Suresh, S.
|0 P:(DE-HGF)0
|b 3
773 _ _ |a 10.1007/s10439-013-0922-3
|0 PERI:(DE-600)1477155-x
|n 2
|p 368-387
|t Annals of biomedical engineering
|v 42
|y 2014
|x 0191-5649
856 4 _ |u https://juser.fz-juelich.de/record/154031/files/FZJ-2014-03445.pdf
|z Published final document.
|y Restricted
909 C O |o oai:juser.fz-juelich.de:154031
|p VDB
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)140336
913 2 _ |a DE-HGF
|b Key Technologies
|l BioSoft Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences
|1 G:(DE-HGF)POF3-550
|0 G:(DE-HGF)POF3-553
|2 G:(DE-HGF)POF3-500
|v Physical Basis of Diseases
|x 0
913 1 _ |a DE-HGF
|b Schlüsseltechnologien
|1 G:(DE-HGF)POF2-450
|0 G:(DE-HGF)POF2-451
|2 G:(DE-HGF)POF2-400
|v Soft Matter Composites
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF2
|l BioSoft
914 1 _ |y 2014
915 _ _ |a Peer review unknown
|0 StatID:(DE-HGF)0040
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
920 1 _ |0 I:(DE-Juel1)IAS-2-20090406
|k IAS-2
|l Theorie der Weichen Materie und Biophysik
|x 0
920 1 _ |0 I:(DE-Juel1)ICS-2-20110106
|k ICS-2
|l Theorie der Weichen Materie und Biophysik
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)IAS-2-20090406
980 _ _ |a I:(DE-Juel1)ICS-2-20110106
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)IBI-5-20200312
981 _ _ |a I:(DE-Juel1)IAS-2-20090406
981 _ _ |a I:(DE-Juel1)ICS-2-20110106


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21